Brintellix 5 mg film-coated tablets

Introduction

Package Leaflet: Information for the Patient

Brintellix 5 mg Film-Coated Tablets

vortioxetine

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.

• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

1. What is Brintellix and what is it used for
2. What you need to know before you take Brintellix
3. How to take Brintellix
4. Possible side effects
5. Storage of Brintellix
6. Contents of the pack and other information

1. What is Brintellix and what is it used for

Brintellix contains the active substance vortioxetine. This belongs to a group of medicines called antidepressants.

Brintellix is used to treat major depressive episodes in adults.

Brintellix has been shown to reduce a broad range of depressive symptoms, including sadness, inner tension (feeling of anxiety), sleep disturbances (reduced sleep), reduced appetite, difficulty concentrating, feelings of worthlessness, loss of interest in pleasurable activities, and feeling of slowness.

2. What you need to know before you take Brintellix

Do not take Brintellix

• if you are allergic to vortioxetine or any of the other ingredients of this medicine (listed in section 6).

• if you are taking other medicines for depression known as monoamine oxidase inhibitors (MAOIs) or selective MAO-A inhibitors. If in doubt, consult your doctor.

Warnings and precautions

Consult your doctor or pharmacist before taking Brintellix if:

• you are taking medicines with a serotonergic effect, such as:

tramadol and similar medicines (strong painkillers).

• sumatriptan and similar medicines with active ingredient names ending in "-triptan" (used to treat migraine).

Taking these medicines with Brintellix may increase the risk of serotonin syndrome. This syndrome can be associated with hallucinations, involuntary jerks, rapid heartbeat, high blood pressure, fever, nausea, and diarrhea.

• you have had seizures.

Your doctor will treat you with caution if you have a history of seizures or unstable/epileptic disorders. Seizures are a potential risk of medicines used to treat depression. Treatment should be discontinued in any patient who experiences seizures or an increase in their frequency.

• you have had mania.

• you have a tendency to bleed or bruise easily or if you are pregnant (see "Pregnancy, breastfeeding, and fertility").
• you have low sodium levels in your blood.
• you are 65 years of age or older.
• you have severe kidney disease.
• you have severe liver disease or a liver disease called cirrhosis.

• you have increased eye pressure or glaucoma. If you experience eye pain and blurred vision during treatment, contact your doctor.

If you are receiving treatment with antidepressants, including vortioxetine, you may also experience feelings of aggression, agitation, anger, and irritability. If this happens, you should consult your doctor.

Suicidal thoughts and worsening of your depression

If you are depressed and/or suffer from anxiety disorders, you may sometimes have thoughts of harming or killing yourself. These may increase when you first start taking antidepressants, as these medicines take time to start working, usually around 2 weeks, although in some cases it may be longer.

You are more likely to have these thoughts:

• If you have previously had thoughts of killing or harming yourself.
• If you are a young adult.

Clinical trial data have shown an increased risk of suicidal behavior in adults under 25 with psychiatric disorders who were treated with an antidepressant.

If at any time you have thoughts of harming or killing yourself, contact your doctor or go directly to a hospital. It may be helpful for you to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety has got worse, or if they are worried about changes in your behavior.

Children and adolescents

Brintellix should not be used in pediatric patients (under 18 years) as its efficacy has not been established. The safety of Brintellix in children and adolescents aged 7 to 17 years is described in section 4.

Taking Brintellix with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

• Tell your doctor if you are taking any of the following medicines: phenelzine, iproniazid, isocarboxazid, nialamide, tranylcypromine (medicines for depression called non-selective monoamine oxidase inhibitors); you must not take any of these medicines with Brintellix. If you have taken any of these medicines, you must wait 14 days before starting to take Brintellix. After stopping Brintellix, you must wait 14 days before taking any of these medicines.

• moclobemide (a medicine for depression).
• selegiline, rasagiline (medicines for Parkinson's disease).
• linezolid (an antibiotic).
• medicines with a serotonergic effect, for example, tramadol or similar medicines (strong painkillers) and sumatriptan and similar medicines with active ingredient names ending in "-triptan" (administered for migraine). Taking these medicines with Brintellix may increase the risk of serotonin syndrome (see section 2).
• lithium (a medicine for depression and mental disorders) or tryptophan.
• medicines known to cause a decrease in sodium levels.
• rifampicin (an antibiotic for tuberculosis and other infections).
• carbamazepine, phenytoin (a medicine for epilepsy or other conditions).
• warfarin, dipyridamole, phenprocoumon, some antipsychotics, phenothiazines, tricyclic antidepressants, aspirin at low doses, and non-steroidal anti-inflammatory drugs (anticoagulants and medicines used to relieve pain). These may increase the tendency to bleed.

Medicines that increase the risk of seizures:

• sumatriptan and similar medicines with active ingredient names ending in "-triptan".

• tramadol (a strong painkiller).
• mefloquine (a medicine to prevent and treat malaria).
• bupropion (a medicine for depression also used to help stop smoking).

• fluoxetine, paroxetine, and other medicines for depression called SSRIs/SNRIs, tricyclics.
• St. John's Wort (Hypericum perforatum) (a medicine for depression).
• quinidine (a medicine for heart rhythm disorders).

• chlorpromazine, chlorprothixene, haloperidol (medicines for mental disorders belonging to the groups called phenothiazines, thioxanthenes, or butyrophenones).

Please talk to your doctor if you are taking any of the medicines mentioned, as your doctor needs to know if you are at risk of having seizures.

If you are given a urine test, taking Brintellix may cause positive results for methadone when some test methods are used, even if you are not taking methadone. If this happens, a more specific test can be done.

Taking Brintellix with alcohol

It is not recommended to combine this medicine with alcohol.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.

Pregnancy

Brintellix should not be used during pregnancy unless your doctor considers it absolutely necessary.

If you take medicines for depression, including Brintellix, during the last 3 months of pregnancy, you should be aware that the following effects may be seen in the newborn: breathing difficulties, blue discoloration of the skin, seizures, changes in body temperature, feeding difficulties, vomiting, low blood sugar, stiff or floppy muscles, exaggerated reflexes, tremors, restlessness, irritability, lethargy, constant crying, and sleep disturbances. If your baby has any of these symptoms, contact your doctor immediately.

Make sure your midwife and/or doctor know you are taking Brintellix. When taken during pregnancy, especially in the last 3 months, medicines like Brintellix may increase the risk of a serious condition in the baby called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and turn blue. These symptoms usually start during the first 24 hours after the baby is born. If this happens to your baby, you should contact your midwife and/or doctor immediately.

If you take Brintellix in the final stage of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know you are taking Brintellix so they can advise you.

Breastfeeding

It is expected that the ingredients of Brintellix pass into breast milk. Brintellix should not be used during breastfeeding. Your doctor will decide whether you should stop breastfeeding or stop taking Brintellix, taking into account the benefit of breastfeeding for the child and the benefit of treatment for you.

Driving and using machines

Brintellix has little or no influence on the ability to drive or use machines. However, as dizziness has been reported, caution is recommended during these activities at the start of treatment with Brintellix or when changing dose.

Brintellix contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".

3. How to take Brintellix

Follow exactly the administration instructions of this medicine given by your doctor.

In case of doubt, consult your doctor or pharmacist again.

The recommended dose of Brintellix is 10 mg of vortioxetine once daily in adults under 65 years of age. Your doctor may increase the dose up to a maximum of 20 mg of vortioxetine once daily or reduce it to a minimum of 5 mg of vortioxetine once daily, depending on your response to treatment.

For elderly patients 65 years of age or older, the initial dose is 5 mg of vortioxetine once daily.

Method of administration

Take one tablet with a glass of water.

The tablet can be taken with or without food.

Duration of treatment

Take Brintellix for as long as your doctor tells you.

Continue taking Brintellix even if it takes some time to start feeling better.

You should continue treatment for at least 6 months after you feel better.

If you take more Brintellix than you should

If you take more Brintellix than you have been prescribed, contact your doctor or go to the nearest hospital emergency department immediately. Take the pack and any remaining tablets with you. Do this even if you feel well. Symptoms in case of overdose are: dizziness, nausea, diarrhea, stomach discomfort, itching all over the body, drowsiness, and flushing (redness of the skin).

After taking doses several times higher than prescribed, seizures (convulsions) and a rare condition called serotonin syndrome have been reported.

If you forget to take Brintellix

Take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.

If you stop taking Brintellix

Do not stop taking Brintellix without talking to your doctor.

Your doctor may decide to gradually reduce your dose before you stop taking this medicine altogether.

Some patients who have stopped taking Brintellix have experienced symptoms such as dizziness, headache, sensation of tingling or sensations like electric shocks (especially in the head), inability to sleep, nausea, or vomiting, anxiety, irritability, or restlessness, feeling tired or trembling. These symptoms may appear in the first week after stopping Brintellix.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects observed were mostly mild or moderate and occurred in the first two weeks of treatment. These effects were usually transient and did not require discontinuation of treatment.

The following side effects have been observed with the frequencies listed:

Very common: may affect more than 1 in 10 people

• nausea.

Common: may affect up to 1 in 10 people

• diarrhea, constipation, vomiting.
• dizziness.
• itching all over the body.
• abnormal dreams.
• increased sweating.
• indigestion.

Uncommon: may affect up to 1 in 100 people

• flushing (redness of the skin).
• night sweats.
• blurred vision.
• involuntary jerks (tremor).
• hallucinations (seeing, hearing, or feeling things that are not there).

Rare: may affect up to 1 in 1,000 people

• dilated pupils (mydriasis), which may increase the risk of glaucoma (see section 2).

Frequency not known: cannot be estimated from the available data

• low sodium levels in the blood (some of the symptoms may be feeling dizzy, weak, confused, sleepy, or very tired, or having nausea or vomiting; more serious symptoms are fainting, seizures, or falls).
• serotonin syndrome (see section 2).

• allergic reactions, which can be severe, and cause swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing, and/or a sudden drop in blood pressure (which can make you feel dizzy or faint).

• hives.

• excessive or unexplained bleeding (including bruising, nosebleeds, gastrointestinal bleeding, and vaginal bleeding).
• rash.
• sleep disorders (insomnia).

• agitation and aggression. If you experience these side effects, contact your doctor (see section 2).
• headache.
• increased levels of a hormone called prolactin in the blood.
• a constant need to move (akathisia).
• grinding your teeth (bruxism).
• inability to open your mouth (trismus).
• restless legs syndrome (an irresistible urge to move your legs to stop uncomfortable sensations, often occurring at night).

secreting milk from the breast (galactorrhea).

A higher risk of sexual dysfunction has been reported with the 20 mg dose, and in some patients, this side effect was observed with lower doses.

An increased risk of bone fractures has been observed in patients taking this type of medicine.

Other side effects in children and adolescents

The side effects observed with vortioxetine in children and adolescents were similar to those observed in adults, except for abdominal pain-related events, which were observed more frequently in children and adolescents than in adults, and suicidal ideation, which was observed more frequently in adolescents than in adults.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Brintellix

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Package Contents and Additional Information

Brintellix Composition

• The active ingredient is vortioxetine. Each film-coated tablet contains 5 mg vortioxetine (as hydrobromide).

• The other ingredients are mannitol (E421), microcrystalline cellulose, hydroxypropylcellulose, sodium glycolate starch (type A), magnesium stearate, hypromellose, Macrogol 400, titanium dioxide (E171), red iron oxide (E172).

Product Appearance and Package Contents

Film-coated tablet (tablet), pink in color and almond-shaped (5 x 8.4 mm), engraved with “TL” on one side and with “5” on the other.

Brintellix 5 mg film-coated tablets are available in blisters of 14, 28, 98, 56x1, 98x1, 126 (9x14), and 490 (5x(98x1)) tablets, and in packs of 100 and 200 tablets.

The package sizes of 56x1, 98x1, and 490 film-coated tablets are presented in unit-dose blisters.

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

• Lundbeck A/S

Ottiliavej 9

2500 Valby

Denmark

You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:

Date of Last Revision of this Leaflet:{MM/YYYY}

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.